Larimar Therapeutics, Inc. (LRMR) Earnings
|
Expand Research on LRMR
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/29/24 | Q423 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/23 | Q323 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/14/23  |
Q323 | -$0.21 | -$0.22 | +$0.01 | N/A | N/A | N/A |  | | Details | |
| 8/10/23 | Q223 | -$0.19 | -$0.20 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/10/23 | Q123 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/2/23 | Q422 | N/A | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A |
